Accessibility Menu
SeaStar Medical logo

SeaStar Medical

(NASDAQ) ICU

Current Price$2.30
Market Cap$8.63M
Since IPO (2021)-100%
5 YearN/A
1 Year-89%
1 Month-6%

SeaStar Medical Financials at a Glance

Market Cap

$8.63M

Revenue (TTM)

$881.00K

Net Income (TTM)

$13.66M

EPS (TTM)

$-14.85

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$2.30

Volume

0

Open

$2.31

Previous Close

$2.30

Daily Range

$2.30 - $2.31

52-Week Range

$2.20 - $25.70

ICU News

No articles available.

ICU: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SeaStar Medical

Industry

Healthcare Equipment and Supplies

Employees

17

CEO

Eric Schlorff

Headquarters

Denver, CO 80216, US

ICU Financials

Key Financial Metrics (TTM)

Gross Margin

95%

Operating Margin

-16%

Net Income Margin

-16%

Return on Equity

-290%

Return on Capital

-1%

Return on Assets

-88%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.63M

Shares Outstanding

3.80M

Volume

0

Short Interest

0.00%

Avg. Volume

104.92K

Financials (TTM)

Gross Profit

$135.00K

Operating Income

$17.84M

EBITDA

$24.58M

Operating Cash Flow

$16.01M

Capital Expenditure

$0.00

Free Cash Flow

$16.01M

Cash & ST Invst.

$1.82M

Total Debt

$574.00K

SeaStar Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$183.00K

+169.1%

Gross Profit

$169.00K

+148.5%

Gross Margin

92.35%

N/A

Market Cap

$8.63M

N/A

Market Cap/Employee

$454.00K

N/A

Employees

19

N/A

Net Income

$3.47M

+22.5%

EBITDA

$3.46M

+17.6%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$13.76M

+561.0%

Accounts Receivable

$221.00K

+225.0%

Inventory

$83.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-87.99%

N/A

Return on Invested Capital

-1.21%

N/A

Free Cash Flow

$3.84M

+23.2%

Operating Cash Flow

$3.84M

+23.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CTXRCitius Pharmaceuticals, Inc.
$0.81-1.60%
AIMDAinos, Inc.
$1.45-0.68%
LNAILunai Bioworks Inc.
$0.39-4.21%
BLRXBioLineRx Ltd.
$2.71+3.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%

Questions About ICU

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.